14-day Premium Trial Subscription Sign Up For FreeGet Free

AxoGen Stock Forecast NASDAQ:AXGN

Price Target and Analyst Ratings

Most Recent Rating

SVB Leerink is very positive about AXGN and gave it a "Buy" rating on May 31, 2021. The price target was set to $27.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-31 Buy Reiterated by SVB Leerink $20.30 $27.00
2021-05-25 Hold Reiterated by Canaccord Genuity $20.56 $24.00
2021-05-12 Hold Target Raised by Canaccord Genuity $20.83 $21.00 → $24.00
2021-05-06 Hold Target Raised by Canaccord Genuity $22.09 $21.00 → $24.00
2021-03-01 Outperform Target Raised by SVB Leerink $22.60 $23.00 → $27.00
2021-03-01 Hold Target Raised by Canaccord Genuity $22.60 $20.00 → $21.00
2021-02-23 Hold Reiterated by Canaccord Genuity $21.40 $20.00 → $21.00
2021-02-23 Hold Reiterated by Canaccord Genuity $21.40
2021-02-23 Hold Target Raised by Canaccord Genuity $21.40 $20.00 → $21.00
2021-02-23 Outperform Target Raised by SVB Leerink $21.40 $23.00 → $27.00
2021-01-12 Overweight Target Raised by Cantor Fitzgerald $20.09 $16.00 → $23.00
2020-10-22 Buy Initiated by Guggenheim $13.35
2020-09-16 Hold Reiterated by Canaccord Genuity $12.88 $13.00
2020-08-06 Outperform Target Raised by SVB Leerink $12.04 $13.50 → $15.50
2020-08-05 Hold Reiterated by BTIG Research $12.31
2020-07-01 Hold Downgraded by BTIG Research $11.73
2020-07-01 Hold Downgraded by Canaccord Genuity $11.73 $12.00
2020-06-15 Buy Initiated by Cantor Fitzgerald $9.82 $16.00
2020-05-07 Buy - Hold Downgraded by Canaccord Genuity $8.32 $12.00

AXGN Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $16.77 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -29.25% during the next 3 months and, with a 90% probability hold a price between $9.06 and $11.86 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-22 $12.70 $14.68 $16.66
2021-09-23 $12.59 $14.57 $16.55
2021-09-24 $12.48 $14.46 $16.44
2021-09-27 $12.37 $14.35 $16.33
2021-09-28 $12.26 $14.24 $16.22
2021-09-29 $12.15 $14.13 $16.11
2021-09-30 $12.04 $14.02 $16.00
2021-10-01 $11.93 $13.91 $15.89
2021-10-04 $11.82 $13.80 $15.78
2021-10-05 $11.71 $13.69 $15.67
2021-10-06 $11.60 $13.58 $15.56
2021-10-07 $11.49 $13.47 $15.45
2021-10-08 $11.38 $13.36 $15.34
2021-10-11 $11.27 $13.25 $15.23
2021-10-12 $11.16 $13.14 $15.12
2021-10-13 $11.05 $13.03 $15.01
2021-10-14 $10.94 $12.92 $14.90
2021-10-15 $10.83 $12.81 $14.79
2021-10-18 $10.72 $12.70 $14.68
2021-10-19 $10.61 $12.59 $14.57
2021-10-20 $10.50 $12.48 $14.46
2021-10-21 $10.39 $12.37 $14.35
2021-10-22 $10.28 $12.26 $14.24
2021-10-25 $10.17 $12.15 $14.13
2021-10-26 $10.06 $12.04 $14.02
2021-10-27 $9.95 $11.93 $13.91
2021-10-28 $9.84 $11.82 $13.80
2021-10-29 $9.73 $11.71 $13.69
2021-11-01 $9.62 $11.60 $13.58
2021-11-02 $9.51 $11.49 $13.47

About AxoGen

AxoGen AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company’s surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf human nerve allograft for bridging nerve discontinuities without the comorbidities associated with another surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptati... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT